VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, cardiometabolic disease and exposomics. Contact us to discuss how you can add breath research to your own research.
There are 5 results matching your search criteriaClear all filters
Improving outcomes of VOC biomarker discovery for diagnosing gastrointestinal disorders
Gastrointestinal Disease, Inflammatory Disease, Microbiome
Breath Biopsy could diagnose IBD via VOCs produced in the gut
Gastrointestinal Disease, Inflammatory Disease
Using exhaled methane to diagnose intestinal methanogen overgrowth